| Project/Area Number |
23592140
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Cerebral neurosurgery
|
|---|
| Research Institution | Kyorin University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
NAGANE Motoo 杏林大学, 医学部, 教授 (60327468)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 悪性リンパ腫 / 脳腫瘍 / 遺伝子解析 / 予後因子 / 治療感受性 / Germinal center / MGMT / Mismatch repair / ゲノム解析 |
|---|
| Research Abstract |
We investigated prognostic markers for primary central nervous system lymphoma (PCNSL) using immunohistochemistry. Age and KPS were strong prognosticators as reported previously. Methotrexate-based chemoradiotherapy achieved a high rate of complete response (83%), improving survival of PCNSL patients. Multiplicity of PCNSL lesions was significantly associated with a short survival. High expression of LRP, drug efflux pump protein, was associated with a poor response to chemotherapy and shorter overall survival, suggesting that LRP may be a clinically relevant drug-resistance factor in PCNSL. Expression of a germinal center marker Bcl-6 was a favorable prognostic factor, whereas c-myc high protein expression was associated with an inferior survival. Low protein expression of mismatch repair proteins, MLH1, MSH2 and MSH6, was a significant indicator for a short survival in patients with PCNSL.
|
